A series of nonsteroidal "dissociated" glucocorticoid receptor agonists was optimized for drug-like properties such as cytochrome P450 inhibition, metabolic stability, aqueous solubility, and hERG ion channel inhibition. This effort culminated in the identification of the clinical candidate compound ( R )-39.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265816 | PMC |
http://dx.doi.org/10.1021/ml500387y | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!